Matches in Library of Congress for { <http://lccn.loc.gov/2005006248> ?p ?o. }
Showing items 1 to 23 of
23
with 100 items per page.
- 2005006248 contributor B10111521.
- 2005006248 created "c2006.".
- 2005006248 date "2006".
- 2005006248 date "c2006.".
- 2005006248 dateCopyrighted "c2006.".
- 2005006248 description "Includes bibliographical references and index.".
- 2005006248 description "Protein tyrosine kinases as targets for cancer and other indications / Mark Pearson, Carlos Garcia-Echeverria, Doriano Fabbro -- Inhibitors of signaling interfaces: targeting Src homology 2 domains in drug discovery / Carlos Garcia-Echeverria -- PI 3-kinase inhibition: a target for therapeutic intervention / Peter M. Finan, Stephen G. Ward -- Src as a target for pharmaceutical intervention: potential and limitations / Mira Susa ... [et al.] -- Activated FLT3 receptor tyrosine kinase as a therapeutic target in leukemia / Blanca Scheijen, James D. Griffin -- JAK kinases in leukemias/lymphomas and multiple myeloma / Renate Burger, Martin Gramatzki -- Glivec (Gleevec, Imatinib, STI571): a targeted therapy for CML / Elisabeth Buchdunger, Renaud Capedeville -- Platelet-derived growth factor: normal function, role in disease, and applications of PDGF antagonists / Tobias Sjoblom ... [et al.] -- Structural biology of protein tyrosine kinases / Sandra W. Cowan-Jacob ... [et al.] -- Testing of signal transduction inhibitors in animal models of cancer / Terence O'Reilly, Robert Cozens -- Phosphoproteomics in drug discovery and development / Michel F. Moran.".
- 2005006248 extent "xiii, 290 p. :".
- 2005006248 identifier "158829384X (alk. paper)".
- 2005006248 identifier 2005006248-d.html.
- 2005006248 identifier 2005006248.html.
- 2005006248 isPartOf "Cancer drug discovery and development".
- 2005006248 issued "2006".
- 2005006248 issued "c2006.".
- 2005006248 language "eng".
- 2005006248 publisher "Totowa, N.J. : Humana Press,".
- 2005006248 subject "616.99/4061 22".
- 2005006248 subject "Cancer Chemotherapy.".
- 2005006248 subject "Protein-tyrosine kinase Inhibitors Therapeutic use.".
- 2005006248 subject "RC271.P76 P76 2006".
- 2005006248 tableOfContents "Protein tyrosine kinases as targets for cancer and other indications / Mark Pearson, Carlos Garcia-Echeverria, Doriano Fabbro -- Inhibitors of signaling interfaces: targeting Src homology 2 domains in drug discovery / Carlos Garcia-Echeverria -- PI 3-kinase inhibition: a target for therapeutic intervention / Peter M. Finan, Stephen G. Ward -- Src as a target for pharmaceutical intervention: potential and limitations / Mira Susa ... [et al.] -- Activated FLT3 receptor tyrosine kinase as a therapeutic target in leukemia / Blanca Scheijen, James D. Griffin -- JAK kinases in leukemias/lymphomas and multiple myeloma / Renate Burger, Martin Gramatzki -- Glivec (Gleevec, Imatinib, STI571): a targeted therapy for CML / Elisabeth Buchdunger, Renaud Capedeville -- Platelet-derived growth factor: normal function, role in disease, and applications of PDGF antagonists / Tobias Sjoblom ... [et al.] -- Structural biology of protein tyrosine kinases / Sandra W. Cowan-Jacob ... [et al.] -- Testing of signal transduction inhibitors in animal models of cancer / Terence O'Reilly, Robert Cozens -- Phosphoproteomics in drug discovery and development / Michel F. Moran.".
- 2005006248 title "Protein tyrosine kinases : from inhibitors to useful drugs / edited by Doriano Fabbro and Frank McCormick.".
- 2005006248 type "text".